1. Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases
    Yanhong Bu et al, 2021, Frontiers in Pharmacology CrossRef
  2. The Role of Sphingolipids Metabolism in Cancer Drug Resistance
    Marina Bataller et al, 2021, Frontiers in Oncology CrossRef